Currently, there are 34.71M common shares owned by the public and among those 25.37M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of 61.00% and 48.09% over the past three months. MASS shares are trading 76.36% year to date (YTD), with the 12-month market performance down to -47.21% lower. It has a 12-month low price of $1.81 and touched a high of $7.56 over the same period. MASS has an average intraday trading volume of 607.53K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 52.91%, 60.48%, and 2.41% respectively.
Institutional ownership of 908 Devices Inc (NASDAQ: MASS) shares accounts for 44.78% of the company’s 34.71M shares outstanding.
It has a market capitalization of $135.11M and a beta (3y monthly) value of 1.01. The earnings-per-share (ttm) stands at -$1.78. Price movements for the stock have been influenced by the stock’s volatility, which stands at 16.05% over the week and 11.40% over the month.
Analysts forecast that 908 Devices Inc (MASS) will achieve an EPS of -0.37 for the current quarter, -0.31 for the next quarter and 0 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.37 while analysts give the company a high EPS estimate of -0.37. Comparatively, EPS for the current quarter was -0.33 a year ago. Earnings per share for the fiscal year are expected to increase by 48.58%, and 15.90% over the next financial year.
Looking at the support for the MASS, a number of firms have released research notes about the stock. Leerink Partners stated their Market Perform rating for the stock in a research note on November 13, 2024, with the firm’s price target at $12-$4. Stephens coverage for the 908 Devices Inc (MASS) stock in a research note released on February 07, 2023 offered a Overweight rating with a price target of $14. SVB Leerink on their part issued Outperform rating on January 12, 2021.
